De. Sakas et al., PERFLUOROCHEMICAL OXYGEN CARRIERS - POTENTIAL USES IN NEUROSCIENCES, Cerebrovascular and brain metabolism reviews, 8(3), 1996, pp. 209-229
In this article we review recent developments in the field of ''first-
'' and ''second-generation'' perfluorochemical (PFC) oxygen carriers.
Particular emphasis is placed on the latest research and its implicati
ons regarding the clinical and experimental neurosciences. These compo
unds are ideally suited to the transportation of O-2 within the vascul
ar system. Two properties that facilitate their use in this respect ar
e their very high solubility coefficients for O-2 and CO2 and their bi
ological inertness. Unfortunately, their widespread use has been limit
ed by logistical difficulties associated particularly with their molec
ular behavior in vivo. However, advances in PFC technology have led to
renewed interest. A potential role for second-generation PFCs in cere
bral protection is exciting. Other possible significant applications a
re slowly becoming established in clinical practice. Currently under i
nvestigation are potential uses in the management of severe head injur
ies, radiotherapy or chemotherapy of malignant brain tumors, protectio
n against air embolism, preservation of organs for transplantation, an
d as a tool in microsurgery of the retina or other parts of the CNS. D
iagnostic neuroimaging applications could include the employment of PF
Cs as adjuncts in ultrasound, Doppler, computed tomography (CT), and m
agnetic resonance (MR) to achieve enhanced imaging and precise staging
of inflammatory, neoplastic, and vascular disease processes. Research
applications could include their use in magnetic resonance imaging an
d spectroscopy in assessing cerebral blood flow, local oxygen tension,
and brain metabolism, in molecule-specific imaging, and as physiologi
cal markers of O-2, ions, and pH.